Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Prozin Pharmaceutical
Jiangxi, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Jiangxi Prozin Pharmaceutical has recently applied for a patent related to an auxiliary device for thin-layer identification of Bupleurum marginatum, indicating active research and development efforts focused on quality control or authentication technologies relevant to herbal medicines. No clinical results are publicly available at this time.
- Therapeutic areas
- GastroenterologyImmunologyInfectious DiseasesOther
- Modalities
- Small moleculeHerbal medicine
- Industry
- Metabolite Diagnostics
Beyond the preview
Go deeper on Jiangxi Prozin Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangxi Prozin Pharmaceutical.